about
The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocolManagement of refractory status epilepticus in adults: still more questions than answersTopiramate in the Treatment of Generalized Convulsive Status Epilepticus in Adults: A Systematic Review with Individual Patient Data AnalysisIntravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy.Effectiveness of topiramate in medically complicated patients with status epilepticus or acute refractory seizuresThe Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.Treatment of Convulsive and Nonconvulsive Status Epilepticus.Status epilepticus in the elderly: epidemiology, clinical aspects and treatmentEnteral topiramate in a pediatric patient with refractory status epilepticus: a case report and review of the literature.The utility of EEG, SSEP, and other neurophysiologic tools to guide neurocritical care.Management of seizures in critically ill patients.Topiramate and its clinical applications in epilepsy.The management of refractory status epilepticus: an update.Generalised convulsive status epilepticus: an overviewTreatment of seizures in the neurologic intensive care unit.Recent developments in the diagnosis and treatment of status epilepticus.Treatment of acute seizures and status epilepticus.How I treat status epilepticus in the Neuro-ICU.The use of valproate and new antiepileptic drugs in status epilepticus.Topiramate in the treatment of partial and generalized epilepsy.Status epilepticus in children.Epilepsy in the elderly: Special considerations and challenges.Pharmacological management of seizures and status epilepticus in critically ill patients.Guidelines for the evaluation and management of status epilepticus.Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study.Status epilepticus: an update.Combination drug therapy for the treatment of status epilepticus.Nonconvulsive seizure control in the intensive care unit.Efficacy of topiramate in children with refractory status epilepticus.Prolonged refractory status epilepticus with early and persistent restricted hippocampal signal MRI abnormality.Efficacy and Tolerability of Second and Third Generation Anti-epileptic Drugs in Refractory Epilepsy: A Network Meta-Analysis.Oral pregabalin as an add-on treatment for status epilepticus.[Refractory status epilepticus: diagnosis, therapy, course, and prognosis].Synergism between topiramate and budipine in refractory status epilepticus in the rat.In nonconvulsive status epilepticus (NCSE), treat to burst-suppression: pro and con.Pediatric refractory partial status epilepticus responsive to topiramate.Post-stroke epilepsyRefractory Status Epilepticus: Experience in a Neurological Intensive Care Unit
P2860
Q26997757-B9B8ED80-0DD8-4604-B2C8-B3416EFD75CCQ27028089-92D4D77B-3F59-4D5D-B88F-878BAD8FBDABQ30396733-A3B8B5C0-732D-48F3-A3FD-AED4232E8AE1Q30830721-41EE976B-3729-4485-8C42-1F8803BDBE21Q33414085-20F40BC4-7E01-489D-9178-C00382196666Q34158012-5D1D09C7-F9EB-48E3-8066-495B38718DFDQ34427751-8B7B8237-B7B7-4798-951A-25C23F07B2B7Q34565197-AA91041B-AB22-431C-8984-87E67D5BA2F2Q35124132-6C219E4E-BAAA-472D-9162-5B9F8AE8497EQ35729640-EBB67584-DA60-477E-821F-F0063C6EE7CEQ35930114-CB1A5126-A03A-49DD-9135-B2F1E2C2D784Q36429751-557923C5-FC65-4A01-9BC4-E4B63C3CF42DQ36625012-9BCBCC55-F267-4986-B9F8-402066356E40Q36651076-C9B90B71-80F6-4F9A-8936-3C232291A3B7Q36735141-DC0DE559-9B99-47B9-8685-04782C81D899Q37000111-6BC71389-4C65-48DF-B7CB-069AB2CDF071Q37019705-9CEE84AC-E315-437A-AF06-AFD4DD4BD0EDQ37078894-335B5A78-AE1B-494B-BFCF-36136026C5D1Q37105997-1B4492D6-827B-4B0C-A35F-F2A4CEA62345Q37129817-45D9B7F6-8055-47B7-B673-BE2C3F304E3EQ37408413-3912C7E1-54FF-4653-B5EC-0FDAE1ED7ABDQ37725946-4D441EB2-ED81-496F-A6D2-30179C38099CQ37867301-9B59029A-6EEB-4C8D-8B65-4AFE60A806F1Q38004984-E13E84A7-185E-4705-BB3D-58B00A574319Q38028609-4D8566BE-A9F0-493B-852B-16B19FC5BDA4Q38107426-20247441-4A19-4A2F-AF3F-FBB79AEA31E8Q38513028-2C5AB0C3-2657-42C7-A652-72AAAA44AB82Q39039579-545FB75C-4378-434D-8230-C9DEF14390E3Q39665790-40C4AB2E-A010-4DB9-B260-18421CAFCDE3Q40429266-CC742710-F00E-4684-BE86-DEE14684B355Q42113049-19515270-141C-415E-B1A8-1071B28D0A27Q43021340-875F5640-A159-4133-A151-1D09C02E5FCFQ44544436-ED3126E7-6662-4131-B309-4C9289EF97F4Q45127636-EAC1B9B2-68CD-47C9-AD5A-52655A03639AQ46252806-72F2E37E-6FCB-4CC9-AB19-908B59801256Q46439328-01D146B2-911B-4BBF-B3ED-0717165D4C9BQ57812977-EE3AEAEC-95F9-41CA-BBED-1A0D7FA0C66BQ59051829-D61C5A13-F3DB-4FED-A981-0FB2320496EC
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The use of topiramate in refractory status epilepticus.
@ast
The use of topiramate in refractory status epilepticus.
@en
type
label
The use of topiramate in refractory status epilepticus.
@ast
The use of topiramate in refractory status epilepticus.
@en
prefLabel
The use of topiramate in refractory status epilepticus.
@ast
The use of topiramate in refractory status epilepticus.
@en
P2093
P1433
P1476
The use of topiramate in refractory status epilepticus.
@en
P2093
E J Waterhouse
L D Morton
L K Garnett
R J DeLorenzo
P304
P356
10.1212/01.WNL.0000042783.86439.27
P407
P577
2003-01-01T00:00:00Z